114 Articles

Chemistry tubes with purple, yellow and white liquids in a red rack
July 31, 2020 • 3 Min

Standard Chemotherapy Plus Novel Drugs for Advanced Pancreatic Cancer

This trial tests the effectiveness of three different novel drugs, including immunotherapy, added to standard treatment for advanced pancreatic cancer.

word cloud in English and Spanish
May 29, 2020 • 5 Min

Eighteen Important Words to Know if You Have Pancreatic Cancer

When you start pancreatic cancer treatment it seems like everyone is speaking a language you don’t know. Here are 18 important words to help you along.

Dr. Manuel Hidalgo
May 26, 2020 • 5 Min

COMBATing Pancreatic Cancer

Dr. Manuel Hidalgo explains the COMBAT trial, which combines immunotherapy, a checkpoint inhibitor, and chemotherapy to attack pancreatic cancer.

Dr. Beatriz Carreno
April 16, 2020 • 5 Min

Targeting Mutant KRAS with Immunotherapy

Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.

The tops of closed lab vials as seen from overhead against a blue-ish background
March 26, 2020 • 2 Min

Combining Two Drugs with Different Approaches to Enhance Treatment

A clinical trial combines epigenetic therapy and immunotherapy to make immunotherapy more effective for patients with pancreatic and bile duct cancers.

Pancreatic Cancer Collective and Lustgarten logo and the Stand Up To Cancer logos
March 23, 2020 • 6 Min

Challenge Grant Recipients Moving Forward

The Pancreatic Cancer Collective awarded four teams a second round of New Therapies Challenge Grants, to further develop new pancreatic cancer treatment.

computer rendering of DNA in Brown and blue against a black background
March 2, 2020 • 2 Min

Testing the Safety of an Immunotherapy Combination After Surgery

A new clinical trial tests the safety of a monoclonal antibody and personalized cancer vaccine plus chemotherapy after surgery to remove pancreatic cancer.

Test tubes with blue and yellow liquids in them
December 13, 2019 • 3 Min

Testing Treatment Combinations to Make Surgery More Effective

Can losartan (a high blood pressure drug) and immunotherapy combined with standard chemotherapy and radiation be an effective combination against pancreatic cancer?

Killer T cells
September 10, 2019 • 4 Min

CAR T Cell Trial Targets Mesothelin

In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.

Survivor Stories
August 22, 2019 • 3 Min

I’ll Never Stop Fighting

When Lynne Holcomb was diagnosed with stage IV pancreatic cancer, she kept fighting through treatment and made it onto a clinical trial.

Dr. Theodore Hong
August 1, 2019 • 4 Min

New Study Combines Checkpoint Inhibitors with Radiation Therapy to Boost Immune Response

Dr. Theodore Hong combines checkpoint inhibitors–a type of immunotherapy–with radiation to boost the immune system in pancreatic cancer treatment.

A yellow paper model of DNA helix against a dark background
July 11, 2019 • 2 Min

Immunotherapy to Attack a Common Pancreatic Cancer Mutation

Researchers are testing a type of immunotherapy to attack a variant of the KRAS mutation; KRAS mutations occur in almost all pancreatic cancers.

a hand holding a petri dish in a lab, in black and white
April 24, 2019 • 2 Min

Immunotherapy for Advanced Pancreatic Cancer and Other Solid Tumors

Researchers are testing the use of tumor-infiltrating lymphocytes, a type of immunotherapy, against advanced pancreatic cancer.

electron microscope image of concentric circles formed by reactive ion etching
March 29, 2019 • 2 Min

Immunotherapy to Enhance Standard Chemotherapy for Advanced Pancreatic Cancer

Researchers are testing an immunotherapy drug approved for other advanced cancers for effectiveness against pancreatic cancer.

Dr. Vinod Balachandran
March 13, 2019 • 5 Min

Pancreatic Cancer Exceptional Responders and the Immune System Link

Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.